Finance

Beta
Ask
Lists
IBIO:NASDAQ
Ibio Inc
$1.63
-1.04%
(-0.017) 1D
Jun 24, 11:13:14 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBIO...
Open
$1.68
High
$1.69
Low
$1.63
Mkt. cap
81.22M
Avg. vol.
802.11K
Volume
104.46K
52-wk high
$3.82
52-wk low
$0.56
EPS
-$0.83
Beta
1.26
Shares outstanding
49.68M
No. of employees
20
Open
$1.68
High
$1.69
Low
$1.63
Mkt. cap
81.22M
Avg. vol.
802.11K
Volume
104.46K
52-wk high
$3.82
52-wk low
$0.56
EPS
-$0.83
Beta
1.26
Shares outstanding
49.68M
No. of employees
20
News stories
From sources across the web
About Ibio Inc
CEO-
Employees20
Founded2008
Headquarters-
SectorBiotechnology
Websiteibioinc.com
Analyst Ratings
Based on 5 analysts giving stock ratings to IBIO in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IBIO in the last 3 months.
Highest
Current $1.63
$6.00 (+267.47%)
Average
$5.40 (+230.72%)
Lowest
$5.00 (+206.22%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Martin Auster
Raymond James
Buy
Initiated
$5.00
+206.2%
06/08/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$5.00
+206.2%
05/16/2026
Roanna Ruiz
Leerink Partners
Buy
Maintained
$6.00
+267.5%
05/15/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$6.00
+267.5%
05/14/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$5.00
+206.2%
05/14/2026
Catherine Novack
JonesTrading
Buy
Initiated
$7.00
+328.7%
03/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
200.00K
100.00K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.22M
3.55M
4.28M
3.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.17M
2.50M
5.16M
5.11M
Operating expense
5.40M
6.05M
9.44M
8.36M
Total operating expenses
5.40M
6.05M
9.44M
8.36M
Operating income
-5.20M
-5.95M
-9.44M
-8.36M
Other non operating income
-
-
-
-
EBT including unusual items
-5.16M
-5.72M
-8.99M
-7.73M
EBT excluding unusual items
-5.16M
-5.72M
-8.99M
-7.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.16M
-5.72M
-8.99M
-7.73M
Net profit margin
-2,581.50%
-5,720.00%
-
-
Earnings per share
-0.32
-0.11
-0.09
-0.06
Interest and investment income
79.00K
267.00K
493.00K
657.00K
Interest expense
-44.00K
-36.00K
-41.00K
-22.00K
Net interest expenses
35.00K
231.00K
452.00K
635.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.00M
-5.76M
-9.30M
-8.21M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer